A Study on Vaccination Technologies and Coverage
Pascale Leroueil, Vice President of Healthcare at the William Davidson Institute at the University of Michigan discusses a recent study where she and co-authors present a method for estimating the impact of vaccine technologies on vaccination coverage rates. They designed the method to help decision-makers better assess the most value for their money, with the goal of improving vaccine coverage for vulnerable communities. She talks about if the methodology can be applied to other types of vaccine technologies and what the pandemic revealed in terms of vaccine coverage that this research might address.
Frequently Asked Questions
What is the main topic discussed in this episode of Health Professional Radio?
This episode covers important developments in healthcare, including updates on Vaccine. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.
How can healthcare professionals benefit from this information?
Healthcare professionals can stay informed about the latest developments in Vaccine and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.
Where can I find more information about Vaccine?
For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.
Pascale R. Leroueil is the vice president of the Healthcare sector at the William Davidson Institute at the University of Michigan (WDI). Her research is focused on applying business practices to sustainably address human health needs in emerging markets. She has worked with both public and private health systems to increase their efficiency of care. She also holds an adjunct appointment at the University of Michigan’s Stephen M. Ross School of Business. Before joining WDI, she worked in vaccine development at the University of Michigan’s Medical School. Leroueil earned her PhD in physical chemistry from the University of Michigan, and her MBA from U-M’s Ross School of Business.
Medical Disclaimer
The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.
